| ZFIN ID: ZDB-EXP-231004-5 |
Experiment Conditions Description: altered light dark cycle, chemical treatment by environment: L-dopa
| altered light dark cycle |
|---|
| Name: | altered light dark cycle |
|---|---|
| Synonyms: | |
| Definition: | |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000148] |
| chemical treatment by environment: L-dopa |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | L-dopa |
|---|---|
| Synonyms: | (-)-3-(3,4-dihydroxyphenyl)-L-alanine, (-)-dopa, (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid, 3,4-Dihydroxy-L-phenylalanine, 3,4-DIHYDROXYPHENYLALANINE, 3-Hydroxy-L-tyrosine, beta-(3,4-dihydroxyphenyl)-L-alanine, beta-(3,4-dihydroxyphenyl)alanine, Dihydroxy-L-phenylalanine, Dopar, L-beta-(3,4-Dihydroxyphenyl)alanine, L-DOPA, levodopa, levodopum |
| Definition: | An optically active form of dopa having L-configuration. Used to treat the stiffness, tremors, spasms, and poor muscle control of Parkinson's disease |
| Ontology: | ChEBI [CHEBI:15765] ( EBI ) |
| Publication: | Larbalestier et al., 2021 |
|---|